Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
The Estée Lauder Companies Inc is a household & personal products business based in the US. The Estée Lauder Companies shares (EL) are listed on the NYSE and all prices are listed in US Dollars. The Estée Lauder Companies employs 44,640 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$321.32|
|52-week range||$202.76 - $347.82|
|50-day moving average||$332.28|
|200-day moving average||$310.69|
|Wall St. target price||$366.40|
|Dividend yield||$2.07 (0.64%)|
|Earnings per share (TTM)||$7.79|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||0.45%|
|1 month (2021-08-24)||-4.82%|
|3 months (2021-06-24)||4.09%|
|6 months (2021-03-24)||12.75%|
|1 year (2020-09-24)||52.68%|
|2 years (2019-09-24)||64.78%|
|3 years (2018-09-24)||123.76%|
|5 years (2016-09-23)||264.52%|
Valuing The Estée Lauder Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Estée Lauder Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Estée Lauder Companies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 41x. In other words, The Estée Lauder Companies shares trade at around 41x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
The Estée Lauder Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9475. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Estée Lauder Companies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Estée Lauder Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.7 billion.
The EBITDA is a measure of a The Estée Lauder Companies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$16.2 billion|
|Operating margin TTM||18.79%|
|Gross profit TTM||$12.4 billion|
|Return on assets TTM||9.58%|
|Return on equity TTM||52.7%|
|Market capitalisation||$116 billion|
TTM: trailing 12 months
There are currently 1.8 million The Estée Lauder Companies shares held short by investors – that's known as The Estée Lauder Companies's "short interest". This figure is 5.8% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting The Estée Lauder Companies shares can be evaluated.
The Estée Lauder Companies's "short interest ratio" (SIR) is the quantity of The Estée Lauder Companies shares currently shorted divided by the average quantity of The Estée Lauder Companies shares traded daily (recently around 923022.91666667). The Estée Lauder Companies's SIR currently stands at 1.92. In other words for every 100,000 The Estée Lauder Companies shares traded daily on the market, roughly 1920 shares are currently held short.
However The Estée Lauder Companies's short interest can also be evaluated against the total number of The Estée Lauder Companies shares, or, against the total number of tradable The Estée Lauder Companies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Estée Lauder Companies's short interest could be expressed as 0% of the outstanding shares (for every 100,000 The Estée Lauder Companies shares in existence, roughly 0 shares are currently held short) or 0.0077% of the tradable shares (for every 100,000 tradable The Estée Lauder Companies shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against The Estée Lauder Companies.
Find out more about how you can short The Estée Lauder Companies stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like The Estée Lauder Companies.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 23.34
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and The Estée Lauder Companies's overall score of 23.34 (as at 12/31/2018) is pretty good – landing it in it in the 39th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like The Estée Lauder Companies is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 6.44/100
Social score: 5.96/100
Governance score: 5.94/100
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. The Estée Lauder Companies scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that The Estée Lauder Companies has, for the most part, managed to keep its nose clean.
|Total ESG score||23.34|
|Total ESG percentile||38.82|
|Level of controversy||2|
Dividend payout ratio: 32.87% of net profits
Recently The Estée Lauder Companies has paid out, on average, around 32.87% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.65% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Estée Lauder Companies shareholders could enjoy a 0.65% return on their shares, in the form of dividend payments. In The Estée Lauder Companies's case, that would currently equate to about $2.07 per share.
While The Estée Lauder Companies's payout ratio might seem fairly standard, it's worth remembering that The Estée Lauder Companies may be investing much of the rest of its net profits in future growth.
The Estée Lauder Companies's most recent dividend payout was on 14 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 August 2021 (the "ex-dividend date").
The Estée Lauder Companies's shares were split on a 2:1 basis on 22 January 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your The Estée Lauder Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for The Estée Lauder Companies shares which in turn could have impacted The Estée Lauder Companies's share price.
Over the last 12 months, The Estée Lauder Companies's shares have ranged in value from as little as $202.7563 up to $347.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Estée Lauder Companies's is 0.9383. This would suggest that The Estée Lauder Companies's shares are less volatile than average (for this exchange).
The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. The company offers a range of skin care products, including moisturizers, serums, cleansers, toners, body care, exfoliators, acne care and oil correctors, facial masks, cleansing devices, and sun care products; and makeup products, such as lipsticks, lip glosses, mascaras, foundations, eyeshadows, nail polishes, and powders, as well as compacts, brushes, and other makeup tools. It also provides fragrance products in various forms comprising eau de parfum sprays and colognes, as well as lotions, powders, creams, candles, and soaps; and hair care products that include shampoos, conditioners, styling products, treatment, finishing sprays, and hair color products, as well as sells ancillary products and services. The company offers its products under Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Smashbox, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, By Kilian, BECCA, Too Faced, Dr. Jart+, DECIEM, and The Ordinary brands. It also holds license arrangements for Tommy Hilfiger, Donna Karan New York, DKNY, Michael Kors, and Ermenegildo Zegna brands.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.